A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

Clinical trial NCT02620046 · COMPLETED

Trial details

NCT number: NCT02620046
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colitis, Ulcerative Crohn's Disease

Start date: 2016-04-15
Primary completion: 2024-06-12
Enrollment: 746

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.